NCT01271920 - Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Advanced HER2-positive Breast Cancer

Interventions

DRUG

AUY922

DRUG

Trastuzumab

Trial Locations (16)

10060

Novartis Investigative Site, Candiolo

15706

Novartis Investigative Site, Santiago de Compostela

21034

Novartis Investigative Site, Dijon

28009

Novartis Investigative Site, Madrid

29010

Novartis Investigative Site, Málaga

44805

Novartis Investigative Site, Saint-Herblain Cédex

45147

Novartis Investigative Site, Essen

59100

Novartis Investigative Site, Prato

72076

Novartis Investigative Site, Tübingen

72703

Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville

119228

Novartis Investigative Site, Singapore

SE-171 76

Novartis Investigative Site, Stockholm

B15 2TT

Novartis Investigative Site, Birmingham

LE1 5WW

Novartis Investigative Site, Leicester

M20 2BX

Novartis Investigative Site, Manchester

OX2 6HE

Novartis Investigative Site, Oxford